vs
Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and MURPHY OIL CORP (MUR). Click either name above to swap in a different company.
MURPHY OIL CORP is the larger business by last-quarter revenue ($613.1M vs $493.8M, roughly 1.2× Pediatrix Medical Group, Inc.). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs 1.9%, a 4.9% gap on every dollar of revenue. On growth, Pediatrix Medical Group, Inc. posted the faster year-over-year revenue change (-1.7% vs -8.4%). Over the past eight quarters, Pediatrix Medical Group, Inc.'s revenue compounded faster (-0.1% CAGR vs -12.2%).
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
Murphy Oil Corporation is an American energy company engaged in hydrocarbon exploration headquartered in Houston, Texas.
MD vs MUR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $493.8M | $613.1M |
| Net Profit | $33.7M | $11.9M |
| Gross Margin | — | — |
| Operating Margin | 9.9% | 9.7% |
| Net Margin | 6.8% | 1.9% |
| Revenue YoY | -1.7% | -8.4% |
| Net Profit YoY | 10.5% | -76.3% |
| EPS (diluted) | $0.40 | $0.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $493.8M | $613.1M | ||
| Q3 25 | $492.9M | $721.0M | ||
| Q2 25 | $468.8M | $683.0M | ||
| Q1 25 | $458.4M | $672.7M | ||
| Q4 24 | $502.4M | $669.6M | ||
| Q3 24 | $511.2M | $753.2M | ||
| Q2 24 | $504.3M | $801.0M | ||
| Q1 24 | $495.1M | $794.8M |
| Q4 25 | $33.7M | $11.9M | ||
| Q3 25 | $71.7M | $-3.0M | ||
| Q2 25 | $39.3M | $22.3M | ||
| Q1 25 | $20.7M | $73.0M | ||
| Q4 24 | $30.5M | $50.4M | ||
| Q3 24 | $19.4M | $139.1M | ||
| Q2 24 | $-153.0M | $127.7M | ||
| Q1 24 | $4.0M | $90.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 99.6% | ||
| Q1 24 | — | 100.0% |
| Q4 25 | 9.9% | 9.7% | ||
| Q3 25 | 13.8% | 0.8% | ||
| Q2 25 | 12.8% | 13.5% | ||
| Q1 25 | 7.0% | 21.4% | ||
| Q4 24 | 7.8% | 12.7% | ||
| Q3 24 | 6.6% | 23.8% | ||
| Q2 24 | -31.3% | 23.0% | ||
| Q1 24 | 3.2% | 19.4% |
| Q4 25 | 6.8% | 1.9% | ||
| Q3 25 | 14.5% | -0.4% | ||
| Q2 25 | 8.4% | 3.3% | ||
| Q1 25 | 4.5% | 10.9% | ||
| Q4 24 | 6.1% | 7.5% | ||
| Q3 24 | 3.8% | 18.5% | ||
| Q2 24 | -30.3% | 15.9% | ||
| Q1 24 | 0.8% | 11.3% |
| Q4 25 | $0.40 | $0.08 | ||
| Q3 25 | $0.84 | $-0.02 | ||
| Q2 25 | $0.46 | $0.16 | ||
| Q1 25 | $0.24 | $0.50 | ||
| Q4 24 | $0.37 | $0.35 | ||
| Q3 24 | $0.23 | $0.93 | ||
| Q2 24 | $-1.84 | $0.83 | ||
| Q1 24 | $0.05 | $0.59 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $375.2M | $377.2M |
| Total DebtLower is stronger | $570.5M | $1.4B |
| Stockholders' EquityBook value | $865.9M | $5.1B |
| Total Assets | $2.2B | $9.8B |
| Debt / EquityLower = less leverage | 0.66× | 0.27× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $375.2M | $377.2M | ||
| Q3 25 | $340.1M | $426.0M | ||
| Q2 25 | $224.7M | $379.6M | ||
| Q1 25 | $99.0M | $392.9M | ||
| Q4 24 | $229.9M | $423.6M | ||
| Q3 24 | $103.8M | $271.2M | ||
| Q2 24 | $19.4M | $333.6M | ||
| Q1 24 | $8.0M | $323.4M |
| Q4 25 | $570.5M | $1.4B | ||
| Q3 25 | $577.2M | $1.4B | ||
| Q2 25 | $583.9M | $1.5B | ||
| Q1 25 | $590.5M | $1.5B | ||
| Q4 24 | $597.1M | $1.3B | ||
| Q3 24 | — | $1.3B | ||
| Q2 24 | — | $1.3B | ||
| Q1 24 | — | $1.3B |
| Q4 25 | $865.9M | $5.1B | ||
| Q3 25 | $890.7M | $5.1B | ||
| Q2 25 | $833.8M | $5.2B | ||
| Q1 25 | $789.2M | $5.1B | ||
| Q4 24 | $764.9M | $5.2B | ||
| Q3 24 | $732.5M | $5.2B | ||
| Q2 24 | $706.5M | $5.3B | ||
| Q1 24 | $856.2M | $5.3B |
| Q4 25 | $2.2B | $9.8B | ||
| Q3 25 | $2.2B | $9.7B | ||
| Q2 25 | $2.1B | $9.8B | ||
| Q1 25 | $2.0B | $9.8B | ||
| Q4 24 | $2.2B | $9.7B | ||
| Q3 24 | $2.1B | $9.7B | ||
| Q2 24 | $2.0B | $9.9B | ||
| Q1 24 | $2.2B | $9.7B |
| Q4 25 | 0.66× | 0.27× | ||
| Q3 25 | 0.65× | 0.28× | ||
| Q2 25 | 0.70× | 0.28× | ||
| Q1 25 | 0.75× | 0.29× | ||
| Q4 24 | 0.78× | 0.25× | ||
| Q3 24 | — | 0.24× | ||
| Q2 24 | — | 0.24× | ||
| Q1 24 | — | 0.25× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $114.1M | $249.6M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 3.39× | 20.92× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $114.1M | $249.6M | ||
| Q3 25 | $137.3M | $339.4M | ||
| Q2 25 | $137.2M | $358.1M | ||
| Q1 25 | $-117.5M | $300.7M | ||
| Q4 24 | $133.0M | $433.6M | ||
| Q3 24 | $91.8M | $429.0M | ||
| Q2 24 | $107.0M | $467.7M | ||
| Q1 24 | $-125.2M | $398.8M |
| Q4 25 | 3.39× | 20.92× | ||
| Q3 25 | 1.91× | — | ||
| Q2 25 | 3.49× | 16.06× | ||
| Q1 25 | -5.66× | 4.12× | ||
| Q4 24 | 4.36× | 8.61× | ||
| Q3 24 | 4.72× | 3.08× | ||
| Q2 24 | — | 3.66× | ||
| Q1 24 | -31.03× | 4.43× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
MUR
Segment breakdown not available.
